The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies - Meier, A.; de Laat, M.; Reiche, D.; Fitzgerald, D.; Sillence, M. (BMC veterinary research, 2019)
Keywords: adverse effects; Animals; Biochemistry; Blood glucose; Blood glucose tests; blood serum; body condition; Body fat; body weight; Carbohydrates; Diabetes; Diabetes therapy; Diet; Drug therapy; Equine metabolic syndrome; Fasting; Fat body; Glucose; Glucose transport; Health aspects; Hematology; Horse Diseases - blood; Horse Diseases - drug therapy; Horses; Hyperinsulinemia; Hyperinsulinism - blood; Hyperinsulinism - drug therapy; Hyperinsulinism - veterinary; Hypoglycemia; Hypoglycemic agents; Hypoglycemic Agents - therapeutic use; Insulin; Insulin - blood; Insulin resistance; Laminitis; Metabolic diseases; Metabolic syndrome; Metabolites; monitoring; Nitriles - therapeutic use; Novels; Ponies; Random Allocation; risk; Safety; Sodium; Sodium-glucose linked transport inhibitor; Studies; Testing; Treatment Outcome; Germany; Sodium-glucose linked transport inhibitor; Equine metabolic syndrome; Laminitis; Insulin